Cargando…

Virological cure, clinical efficacy and safety of Remdesivir supplementation against SARS-CoV 2 infection; evidence from human studies

Detalles Bibliográficos
Autores principales:	Ghazvini, K., Keikha, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Masson SAS. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538068/ http://dx.doi.org/10.1016/j.phclin.2020.08.007

Ejemplares similares

Multivalent vaccines against new SARS-CoV-2 hybrid variants
por: Ghazvini, Kiarash, et al.
Publicado: (2023)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

What is the efficacy of BCG vaccination in the protection from COVID-19 in European countries?
por: Ghazvini, K., et al.
Publicado: (2021)

Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2
por: Xie, Yuanchao, et al.
Publicado: (2021)

What are the clinical benefits of tocilizumab for COVID-19 patients? Evidence from available case-control studies
por: Ghazvini, Kiarash, et al.
Publicado: (2021)

Multivalent vaccines against new SARS-CoV-2 hybrid variants
por: Ghazvini, Kiarash, et al.
Publicado: (2023)

Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment
por: Yoon, Jin Gu, et al.
Publicado: (2022)

Extensive environmental contamination and prolonged severe acute respiratory coronavirus-2 (SARS CoV-2) viability in immunosuppressed recent heart transplant recipients with clinical and virologic benefit with remdesivir
por: Rajakumar, Irina, et al.
Publicado: (2021)

Clinical efficacy of vitamin D supplementation on pulmonary TB patients: The evidence of clinical trials
por: Karbalaei, Mohsen, et al.
Publicado: (2020)

Comment on “nontuberculous mycobacterial infection after lung transplantation: a report of four cases”
por: Keikha, Masoud, et al.
Publicado: (2019)

Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not?
por: Keikha, Masoud
Publicado: (2022)

Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not?
por: Keikha, Masoud
Publicado: (2022)

The efficacy and safety of IBI314 on delta and omicron variant of SARS-CoV-2: First-in-human evidence
por: Sang, Ling, et al.
Publicado: (2022)

Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir
por: Nakaya, Aya, et al.
Publicado: (2022)

Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir
por: Nakaya, Aya, et al.
Publicado: (2023)

Global challenge with the SARS-CoV-2 omicron BA.2 (B.1.1.529.2) subvariant: Should we be concerned?
por: Roohani, Jalil, et al.
Publicado: (2022)

Vitamin D supplementation: An alternative to enhance the effectiveness of vaccines against SARS-CoV-2?
por: Inserra, Felipe, et al.
Publicado: (2021)

Response to: Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis
por: Boglione, Lucio, et al.
Publicado: (2021)

Efficacy and Safety of Remdesivir over Two Waves of the SARS-CoV-2 Pandemic
por: Poliseno, Mariacristina, et al.
Publicado: (2021)

Remdesivir in Breastfeeding
por: Sadati, Elham, et al.
Publicado: (2022)

Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis – Authors reply
por: Kumar, Jogender, et al.
Publicado: (2021)

Remdesivir reduced upper respiratory tract SARS-CoV-2 viral RNA concentration in COVID-19 patients who developed pneumonitis
por: Lai, Christopher KC, et al.
Publicado: (2022)

SARS-CoV-2 Vaccination in the Context of Ongoing HIV Cure-Related Research Studies
por: Peluso, Michael J., et al.
Publicado: (2021)

Remdesivir and COVID-19
por: Ferrara, Francesco, et al.
Publicado: (2020)

Anaphylaxis Due to Remdesivir
por: Hopkins, Brian J., et al.
Publicado: (2021)

Living evidence for SARS-CoV-2()
por: Santillan-Garcia, A.
Publicado: (2021)

Therapeutic Efficacy and Outcomes of Remdesivir versus Remdesivir with Tocilizumab in Severe SARS-CoV-2 Infection
por: Vulturar, Damiana-Maria, et al.
Publicado: (2022)

Comment on ‘Necrotizing fasciitis in neonate by Lichtheimia ramosa: A case study’
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Expression changes of cytotoxicity and apoptosis genes in HTLV-1-associated myelopathy/tropical spastic paraparesis patients from the perspective of system virology
por: Ghazvini, Kiarash, et al.
Publicado: (2020)

Successful management of remdesivir extravasation
por: Conde-Estévez, David, et al.
Publicado: (2022)

5-Aminolevulinic acid antiviral efficacy against SARS-CoV-2 omicron variant in vitro
por: Ngwe Tun, Mya Myat, et al.
Publicado: (2022)

Efficacy of Tixagevimab and Cilgavimab Against SARS-CoV-2 Infections in Patients with Inborn Errors of Immunity
por: Johnson, Sarah, et al.
Publicado: (2023)

SARS-CoV-2 Vaccination and Solid Organ Transplant Patients: Data Needed to Inform Safety and Efficacy
por: Ison, Michael G., et al.
Publicado: (2021)

Use of remdesivir in kidney transplant recipients with SARS-CoV-2 Omicron infection
por: Cacho, Judit, et al.
Publicado: (2022)

Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in mice.
por: Schäfer, Alexandra, et al.
Publicado: (2021)

Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets
por: Cox, Robert M., et al.
Publicado: (2021)

Status of Remdesivir: Not Yet Beyond Question!
por: Chatterjee, Saptarshi
Publicado: (2021)

Clinical and virological characteristics of SARS-CoV-2 Omicron BA.2.2 variant outbreaks during April to May, 2022, Shanghai, China
por: Ao, Yuanyun, et al.
Publicado: (2022)

PQQ Supplementation and SARS-CoV-2 Spike Protein-Induced Heart Inflammation
por: Boretti, Alberto
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o9897nnt41eti29pf2demh920l